Lupin Blasts FDA's Call On Celebrex Generic Exclusivity
Lupin Pharmaceuticals Inc. sued the U.S. Food and Drug Administration in Maryland federal court Friday over the agency's decision to grant another drug company exclusivity to make a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article